Evolving role of FDG-PET-based global disease assessment and detection of response to nivolumab treatment in patients with non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Seraj, Siavash Mehdizadeh [2 ]
Jahangiri, Pegah [2 ]
Zadeh, Mahdi Zirakchian [1 ]
Kalboush, Eman [2 ]
Werner, Thomas [2 ]
Alavi, Abass [2 ]
Hunt, Stephen [2 ]
机构：
[1] Childrens Hosp Philadelphia, Dept Radiol, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2019年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1347
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer
    Haruki Kobayashi
    Shota Omori
    Kazuhisa Nakashima
    Kazushige Wakuda
    Akira Ono
    Hirotsugu Kenmotsu
    Tateaki Naito
    Haruyasu Murakami
    Masahiro Endo
    Toshiaki Takahashi
    International Journal of Clinical Oncology, 2017, 22 : 690 - 697
  • [42] Response to the treatment immediately before nivolumab monotherapy may predict clinical response to nivolumab in patients with non-small cell lung cancer
    Kobayashi, Haruki
    Omori, Shota
    Nakashima, Kazuhisa
    Wakuda, Kazushige
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Murakami, Haruyasu
    Endo, Masahiro
    Takahashi, Toshiaki
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2017, 22 (04) : 690 - 697
  • [43] Non-small cell lung cancer: FDG-PET imaging
    Erasmus, JJ
    McAdams, HP
    Patz, EF
    JOURNAL OF THORACIC IMAGING, 1999, 14 (04) : 247 - 256
  • [44] Hyponatraemia as an unrecognised risk factor in non-small cell lung cancer (NSCLC) treatment with nivolumab.
    Grohe, Christian
    Gwynn, Simon
    Evans, Richard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] The evolving role of radiotherapy in non-small cell lung cancer
    Brown, Sean
    Banfill, Kathryn
    Aznar, Marianne C.
    Whitehurst, Philip
    Finn, Corinne Faivre
    BRITISH JOURNAL OF RADIOLOGY, 2019, 92 (1104):
  • [46] Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer
    Takatoshi Enomoto
    Akihiro Tamiya
    Kinnosuke Matsumoto
    Yuichi Adachi
    Koji Azuma
    Yuji Inagaki
    Shunichi Kouno
    Yoshihiko Taniguchi
    Nobuhiko Saijo
    Kyoichi Okishio
    Shinji Atagi
    Clinical and Translational Oncology, 2021, 23 : 582 - 590
  • [47] The evolving role of cetuximab in non-small cell lung cancer
    Lilenbaum, Rogerio C.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4432S - 4435S
  • [48] Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer
    Enomoto, T.
    Tamiya, A.
    Matsumoto, K.
    Adachi, Y.
    Azuma, K.
    Inagaki, Y.
    Kouno, S.
    Taniguchi, Y.
    Saijo, N.
    Okishio, K.
    Atagi, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (03): : 582 - 590
  • [49] A Case of Non-Small Cell Lung Cancer with Possible "Disease Flare" on Nivolumab Treatment
    Chubachi, Shotaro
    Yasuda, Hiroyuki
    Irie, Hidehiro
    Fukunaga, Koichi
    Naoki, Katsuhiko
    Soejima, Kenzo
    Betsuyaku, Tomoko
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2016, 2016
  • [50] Nivolumab treatment beyond progression disease in advanced non-small cell lung cancer
    Enomoto, T.
    Tamiya, A.
    Matsumoto, K.
    Adachi, Y.
    Azuma, K.
    Inagaki, Y.
    Kouno, S.
    Taniguchi, Y.
    Saijo, N.
    Okishio, K.
    Atagi, S.
    ANNALS OF ONCOLOGY, 2019, 30 : 28 - 28
12345